<?xml version="1.0" encoding="UTF-8"?>
<ref id="B67">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Gauger</surname>
    <given-names>P. C.</given-names>
   </name>
   <name>
    <surname>Vincent</surname>
    <given-names>A. L.</given-names>
   </name>
   <name>
    <surname>Loving</surname>
    <given-names>C. L.</given-names>
   </name>
   <name>
    <surname>Lager</surname>
    <given-names>K. M.</given-names>
   </name>
   <name>
    <surname>Janke</surname>
    <given-names>B. H.</given-names>
   </name>
   <name>
    <surname>Kehrli</surname>
    <given-names>M. E.</given-names>
    <suffix>Jr.</suffix>
   </name>
   <etal/>
  </person-group>. (
  <year>2011</year>). 
  <article-title>Enhanced pneumonia and disease in pigs vaccinated with an inactivated human-like (delta-cluster) H1N2 vaccine and challenged with pandemic 2009 H1N1 influenza virus</article-title>. 
  <source>Vaccine</source>
  <volume>29</volume>, 
  <fpage>2712</fpage>â€“
  <lpage>2719</lpage>. 
  <pub-id pub-id-type="doi">10.1016/j.vaccine.2011.01.082</pub-id>
  <?supplied-pmid 21310191?>
  <pub-id pub-id-type="pmid">21310191</pub-id>
 </mixed-citation>
</ref>
